Citadel Advisors
TBI

Citadel Advisors’s Trueblue TBI Stock Holding History

Citadel Advisors’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Buy
+26,800
New +$119K ﹤0.01% 11980
2025
Q2 		– Sell
-3,900
Closed -$20.7K – 15032
2025
Q1 		$20.7K Buy
3,900
+2,400
+160% +$16.4K ﹤0.01% 13117
2024
Q4 		$12.6K Buy
1,500
+500
+50% +$3.86K ﹤0.01% 13491
2024
Q3 		$7.89K Buy
1,000
+300
+43% +$2.7K ﹤0.01% 13336
2024
Q2 		$7.21K Sell
700
-2,500
-78% -$27.1K ﹤0.01% 13268
2024
Q1 		$40.1K Sell
3,200
-3,700
-54% -$47.8K ﹤0.01% 12391
2023
Q4 		$106K Sell
6,900
-1,000
-13% -$14K ﹤0.01% 10860
2023
Q3 		$116K Buy
7,900
+1,700
+27% +$26.5K ﹤0.01% 10705
2023
Q2 		$110K Buy
6,200
+3,800
+158% +$64.4K ﹤0.01% 10789
2023
Q1 		$42.7K Buy
2,400
+2,000
+500% +$37.4K ﹤0.01% 12363
2022
Q4 		$7.83K Buy
+400
New +$8.11K ﹤0.01% 13793
2016
Q1 		– Sell
-1,100
Closed -$28K – 7914
2015
Q4 		$28K Buy
1,100
+900
+450% +$24.3K ﹤0.01% 7710
2015
Q3 		$4K Sell
200
-3,300
-94% -$84.6K ﹤0.01% 8668
2015
Q2 		$105K Buy
3,500
+3,400
+3,400% +$95.8K ﹤0.01% 7024
2015
Q1 		$2K Sell
100
-3,400
-97% -$76.4K ﹤0.01% 8421
2014
Q4 		$78K Buy
+3,500
New +$83K ﹤0.01% 6861
2014
Q3 		– Sell
-100
Closed -$3K – 8394
2014
Q2 		$3K Sell
100
-2,300
-96% -$63K ﹤0.01% 7804
2014
Q1 		$70K Buy
2,400
+1,500
+167% +$40.2K ﹤0.01% 6494
2013
Q4 		$23K Sell
900
-200
-18% -$4.99K ﹤0.01% 6392
2013
Q3 		$26K Sell
1,100
-900
-45% -$22.5K ﹤0.01% 6099
2013
Q2 		$42K Buy
+2,000
New +$43.1K ﹤0.01% 5750

Other funds holding TBI

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Citadel Advisors's TBI Position: Q1 2026 in Review

Citadel Advisors increased its Trueblue (TBI) stake by 115% in Q1 2026, buying an estimated $77.4K and bringing the position to 32,617 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #11823.

Citadel Advisors first reported a position in TBI in Q2 2013 and has held it in 46 quarters since. The position peaked at $8.35M in Q1 2024. 105 funds tracked by Wall St. Rank hold TBI as of Q1 2026.

  • Citadel Advisors held 32,617 shares of Trueblue worth $128K as of Q1 2026.
  • Citadel Advisors bought 17,418 Trueblue shares in Q1 2026, an estimated $77.4K.
  • Trueblue made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11823 holding.
  • Citadel Advisors first reported a position in Trueblue in Q2 2013 and has held it in 46 quarters since.
  • Citadel Advisors's Trueblue position peaked at $8.35M in Q1 2024.
  • 105 funds tracked by Wall St. Rank held Trueblue as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.